View Older Stories View More Recent Stories

Jan 16, 2020 10:33PM Exclusive: Temasek, Trustbridge target majority stake in WeWork China at $1 billion valuation – sources
Jan 14, 2020 11:30AM cbdMD, Inc. Announces Closing of $18.4 Million Underwritten Public Offering of Common Stock
Jan 10, 2020 05:48AM cbdMD, Inc. (YCBD) Prices 16M Share Common Offering at $1/Sh
Jan 9, 2020 07:46PM cbdMD, Inc. Prices Underwritten Public Offering of Common Stock
Jan 9, 2020 09:00AM The Benchmark Company Adds Industrial Research Team to Its Growing Platform
Jan 9, 2020 09:00AM The Benchmark Company Adds Industrial Research Team to Its Growing Platform
Dec 27, 2019 08:05AM AInnovation Raises Nearly US$60 million in Series B Financing to Deepen AI Application in Industries
Dec 20, 2019 02:21PM Youngevity International, Inc. Announces Closing of $5.58 Million Public Offering of Series D Cumulative Redeemable Perpetual Preferred Stock
Dec 18, 2019 08:00AM Youngevity International, Inc. Announces Pricing of $5.58 Million of Series D Cumulative Redeemable Perpetual Preferred Stock Offering
Dec 10, 2019 12:00PM Hiperbaric Receives 2019 European Technology Award Recognizing Company's High Pressure Technology Innovation
Dec 4, 2019 09:46AM Expedia CEO, CFO resign after clash over strategy with board
Dec 2, 2019 09:38AM Edward Rubin Joins the Benchmark Company as Co-Head of Investment Banking
Dec 2, 2019 09:37AM Edward Rubin Joins the Benchmark Company as Co-Head of Investment Banking
Dec 2, 2019 08:00AM NAPCO Security Technologies to Attend the Benchmark Discovery Conference December 4, 2019
Nov 25, 2019 08:00PM Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
Nov 25, 2019 08:00PM Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
Nov 25, 2019 08:31AM OSS to Present at Benchmark’s 8th Annual Discovery 1x1 Conference, December 4, 2019
Nov 25, 2019 08:31AM OSS to Present at Benchmark’s 8th Annual Discovery 1x1 Conference, December 4, 2019
Nov 21, 2019 05:31PM CNS Pharmaceuticals Announces Full Exercise of Over-Allotment Option
Nov 21, 2019 04:45PM Harvard Bioscience to attend Benchmark’s 8th Annual Discovery One-on-One Conference
Nov 21, 2019 04:45PM Harvard Bioscience to attend Benchmark’s 8th Annual Discovery One-on-One Conference
Nov 21, 2019 09:00AM MTBC to Present at Benchmark, LD Micro Conferences in December
Nov 21, 2019 09:00AM MTBC to Present at Benchmark, LD Micro Conferences in December
Nov 21, 2019 08:29AM Titan Medical to Participate in Two Investment Conferences in December
Nov 20, 2019 09:00AM Everspin to Participate at the Benchmark Discovery Conference on December 4
Nov 20, 2019 09:00AM Adesto® to Participate at the Benchmark Discovery Conference on December 4
Nov 20, 2019 08:30AM Youngevity International, Inc. Nasdaq YGYI, to Present at The Benchmark Company's 8th Annual Discovery 1x1 Investor Conference
Nov 19, 2019 08:30AM Boxlight to Present at The Benchmark Company’s 8th Annual Discovery 1x1 Investor Conference on December 4, 2019
Nov 15, 2019 08:33AM Taronis (TRNX) Completes $3.5 Million Convertible Preferred Offering
Nov 15, 2019 08:30AM Taronis Completes $3.5 Million Convertible Preferred Offering
Nov 15, 2019 08:30AM Taronis Completes $3.5 Million Convertible Preferred Offering
Nov 13, 2019 04:30PM The Benchmark Company, LLC Announces Closing of Initial Public Offering of CNS Pharmaceuticals, Inc.
Nov 13, 2019 04:30PM The Benchmark Company, LLC Announces Closing of Initial Public Offering of CNS Pharmaceuticals, Inc.
Nov 13, 2019 04:15PM CNS Pharmaceuticals Announces Closing Of Initial Public Offering of Common Stock
Nov 8, 2019 10:47AM CNS Pharmaceuticals (CNSP) IPO Opens Flat
Nov 7, 2019 08:00PM CNS Pharmaceuticals Announces Pricing Of Initial Public Offering
Nov 7, 2019 04:10PM ACM Research to Participate in Upcoming Investor Conferences
Nov 6, 2019 05:00AM EnviroLeach Technologies to Participate in Upcoming Investor Conferences
Nov 1, 2019 10:00AM Seelos Therapeutics to Participate in Upcoming Investor Conferences in December
Nov 1, 2019 10:00AM Seelos Therapeutics to Participate in Upcoming Investor Conferences in December
Oct 25, 2019 05:49AM Biolase (BIOL) Prices 7.82M Share Common Offering at $0.5750/Sh; Announces Concurrent Private Placement of Convertible Preferred Shares
Oct 24, 2019 09:35PM BIOLASE Announces Pricing of $8.5 Million Public Offering of Common Stock and Concurrent Private Placement of Convertible Preferred Stock
Oct 23, 2019 08:35AM CSE & OTC Markets Cannabis Live-Stream Investor Conference & Webinar October 30th
Oct 16, 2019 04:30PM cbdMD, Inc. Announces Closing of $5.0 Million 8.0% Series A Cumulative Convertible Preferred Stock Offering
Oct 10, 2019 08:31PM cbdMD, Inc. Announces Pricing of $5.0 Million 8.0% Series A Cumulative Convertible Preferred Stock Offering
Oct 7, 2019 06:00AM Innovate Biopharmaceuticals to Merge with RDD Pharma Creating New Gastroenterology Company Focused on Specialty, Rare and Orphan Diseases
Sep 26, 2019 06:43AM Companies with NDRs 09/26
Sep 25, 2019 11:54AM The Benchmark Company, LLC Announces Closing of Public Offering of Series D Cumulative Redeemable Perpetual Preferred Stock Offering for Youngevity International, Inc.
Sep 25, 2019 11:54AM The Benchmark Company, LLC Announces Closing of Public Offering of Series D Cumulative Redeemable Perpetual Preferred Stock Offering for Youngevity International, Inc.
Sep 24, 2019 11:37AM Youngevity International, Inc. Announces Closing of Public Offering of Series D Cumulative Redeemable Perpetual Preferred Stock Offering
View More Recent Stories View Older Stories